-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-26
The Hoechst 33342/PI Double Staining Kit provides a two-color fluorescence workflow for distinguishing nuclear chromatin changes from loss of cell membrane integrity in cultured cells. It is intended for research use only; it should not be used as a standalone diagnostic test or as definitive proof of a specific cell-death mechanism.
-
L-Alanyl-L-Glutamine (B8228): Lab Guide
2026-08-26
This guide explains how to use L-Alanyl-L-Glutamine as a water-soluble L-Ala-L-Gln dipeptide for gastrointestinal, nutritional, and aqueous research workflows. It is suitable where glutamine delivery and solution handling are important, but it should not be selected for DMSO- or ethanol-based protocols or long-term storage of prepared solutions.
-
Fluo-4 AM for Podocyte Calcium Assays
2026-08-25
Fluo-4 AM converts transient Ca2+ flux into a practical live-cell readout for podocyte biology, receptor trafficking, and diabetic nephropathy research. This workflow combines sensitive fluorescence imaging with experimental controls that help distinguish calcium signaling from dye-loading or cell-health artifacts.
-
N4-Acetylcytidine: A Smarter Assay Strategy
2026-08-25
N4-Acetylcytidine is more than an RNA modification standard: it is a chemically defined probe for separating free-nucleoside metabolism from RNA-bound ac4C biology. This guide translates recent ASCH-domain structural findings into practical assay-selection, handling, and interpretation strategies.
-
LRRC8A–Caveolin-1 Signaling in PDAC Growth
2026-08-24
The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 axis that links cell-volume regulation to KRAS/EGFR signaling, ribosome biogenesis, and biosynthetic growth in pancreatic ductal adenocarcinoma. Its integrated genetic, pharmacological, organoid, xenograft, and proteomic experiments position membrane organization as a mechanistic determinant of tumor-cell expansion and a potential vulnerability.
-
AZD1390 and G4 Stress in ATM Research
2026-08-24
Explore how AZD1390, a selective ATM kinase inhibitor, can separate DNA damage signaling from G-quadruplex replication stress. This article translates REV1–DHX36 findings into a rigorous assay framework for radiosensitization and cancer research.
-
CD36 Lipid Signaling Drives Immune Escape in AML
2026-08-23
A 2024 Cell Reports Medicine study identifies a non-canonical CD36 lipid-sensing program that enables AML cells to suppress T-cell activity and resist decitabine. The work connects OxLDL and palmitate uptake to TLR4-LYN-MYD88-NF-κB signaling and shows that statin-mediated lipid restriction can improve decitabine responses in preclinical models.
-
Phenytoin for Dynamic Myelin Damage Assays
2026-08-22
Phenytoin can help dissect how sodium-channel-dependent excitability influences early myelin damage. This assay-focused guide translates longitudinal myelin imaging findings into practical electrophysiology, dosing, timing, and interpretation decisions.
-
IWP-L6: A Functional Wnt Signaling Research Map
2026-08-22
IWP-L6 is a sub-nanomolar Porcupine inhibitor for dissecting Wnt signaling modulation across developmental and metabolic assays. This guide connects upstream Porcn enzyme inhibition with assay timing, branching morphogenesis, regeneration, and Wnt-driven osteoblast metabolism.
-
Sex Differences in Angiotensin II Hypertension
2026-08-21
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II produces a substantially larger hypertensive response in conscious male mice than in female mice, with gonadectomy shifting the response in both sexes. Telemetry, baroreflex testing, and ganglionic blockade linked this sex difference to hormone-dependent cardiovascular regulation and a greater sympathetic contribution in males.
-
Adiponectin, TLR4, and Cognitive Deficits After Splenectomy
2026-08-20
This reference study uses an aged-rat splenectomy model to connect adiponectin treatment with reduced neuroinflammation, oxidative stress, and postoperative cognitive impairment. Pharmacological comparison with TAK-242 and LPS supports a mechanistic role for the TLR4/MyD88/NF-κB axis, while also highlighting important limits for translating pretreatment findings to clinical perioperative neurocognitive disorder.
-
In Situ CAR Macrophage Programming for Peritoneal Tumors
2026-08-20
Gu et al. develop a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity and use it to compare 36 CAR designs. The CD3ζ–TLR4 intracellular-domain configuration promoted inflammatory macrophage activity, remodeled the tumor microenvironment, increased TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and enhanced responses to PD-1/PD-L1 blockade.
-
Rhodamine 123 Transport Assay Workflows
2026-08-19
Build sensitive, low-disruption workflows for real-time P-glycoprotein activity, uptake kinetics, and membrane transport process analysis. This guide also shows how to use Rhodamine 123 alongside ABCG2-focused chemosensitization studies without confusing transporter-specific readouts.
-
VX-745 Workflow for p38α MAPK Research
2026-08-19
VX-745 provides a practical way to connect p38α MAPK inhibition with cytokine secretion, cell survival, and disease-model endpoints. This workflow emphasizes formulation control, time-resolved signaling assays, and orthogonal validation for inflammation, aging, and multiple myeloma research.
-
Berberine, Tuft Cells, and Estrogen-Deficiency Bone Loss
2026-08-18
A 2026 Phytomedicine study identifies an intestine-to-bone mechanism in which berberine increases microbial butyrate, activates GPR41, and expands intestinal tuft cells. In ovariectomized models, this pathway restored gut barrier function and improved the Th17/Treg imbalance associated with estrogen deficiency, providing a mechanistic framework for postmenopausal osteoporosis research.